Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

DYADIC INTERNATIONAL INC (DYAI)

$1.19 -1.65% NASDAQ: DYAI · 15-min delayed
  • JUPITER, Florida
  • Public · NASDAQ: DYAI
  • 5 employees
$25.9MMarket cap
$3.1MRevenue · FY2025
-$7.4MNet income
5Employees
DYAINASDAQ
2004IPO

About DYADIC INTERNATIONAL INC

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$3.1M
Net income
-$7.4M
Total assets
$9.9M
Market cap
$25.9M
Gross margin
24.9%
Operating margin
-232.8%
Net margin
-238.3%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$3.1M
Cost of revenue
$2.3M
Gross profit
$770.5K
Operating expenses
$8.0M
Operating income
-$7.2M
Net income
-$7.4M
EPS (basic)
$-0.23
EPS (diluted)
$-0.23

Balance sheet

Total assets
$9.9M
Current assets
$9.9M
Total liabilities
$8.7M
Current liabilities
$3.7M
Shareholders’ equity
$1.2M

Cash flow

Operating cash flow
-$5.7M
Investing cash flow
$82.1K
Financing cash flow
$5.0M
Net cash flow
-$655.2K

Statements via Polygon.io (SEC filings)

NASDAQ: DYAI
$1.19 -1.65%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.68 $1.47

52-week range

Market cap
$25.9M
EPS (diluted)
$-0.23
Shares outstanding
21.8M
Open
Day range
Prev close
Volume
IPO date
Nov 5, 2004

Dyadic International Inc (DYAI) Stock Price

  • Reported a net loss of $7.4M in FY2025.
  • Revenue grew 29% from FY2021 to FY2025.
  • Gross margin of 24.9%, net margin -238.3%.
  • Trading 19% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review DYADIC INTERNATIONAL INC.

Write a review
Newsroom

News about DYADIC INTERNATIONAL INC

News & sentiment via Polygon.io

FAQ

Dyadic International Inc: frequently asked questions

Is Dyadic International Inc an American company?

Dyadic International Inc is a US-based company headquartered in Jupiter, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Dyadic International Inc headquartered?

Dyadic International Inc is headquartered in Jupiter, Florida, United States.

Is Dyadic International Inc publicly traded?

Yes — Dyadic International Inc is a publicly traded company. Its stock trades under the ticker symbol DYAI on the NASDAQ.

What does Dyadic International Inc do?

Dyadic International Inc is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →